The anti-inflammatory effects of Alisma herb extract on allergic asthma mouse model

Molecular and Cellular Toxicology

Volumn 10, Issue 2, 2014, Pages 197-206

  Shin, Min Hee ^a   Park, Yu Jin ^a   Kim, Ki Suk ^a   Cho, Dong Hyuk ^a   Uh, In Joon ^a   Kim, Kang Hoon ^a   Ha, In Jin ^b   Chung, Won Seok ^a   Jung, Hee Jae ^a   Jung, Sung Ki ^a   Jang, Hyeung Jin ^a  

^a Kyung Hee University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Alisma canaliculatum (AC); Antiinflammatory; Asthma; Inducible nitric oxide synthase (iNOS); NF B

Indexed keywords

10 O METHYLALISMOXIDE; 11 DEOXYALISOL C; 4,12 DIHYDROXYGUAIAN 6,10 DIENE; ALISMA CANALICULATUM EXTRACT; ALISMOL; ALISMOXIDE; ALISOL B; ALISOL B 23 ACETATE; ALISOL C 23 ACETATE; ALISOLIDE; ANTIINFLAMMATORY AGENT; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; OVALBUMIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALISMA; ALISMA CANALICULATUM; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HISTOPATHOLOGY; LUNG PARENCHYMA; MEDICINAL PLANT; METABOLITE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT ALLERGY; TIME OF FLIGHT MASS SPECTROMETRY; TRANSCRIPTION INITIATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84921387782     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-014-0021-z     Document Type: Article

References (39)

1. Wenzel, S. E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18:716-725 (2012).
2. Holgate, S. T. Pathogenesis of asthma. Clinical Allergy 38:872-897 (2008).
3. Grunig, G. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263 (1998).
4. Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261 (1998).
5. Zhang, D. H. et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11:473-482 (1999).
6. Busse, W. W. & Lemanske, R.F. Jr. Asthma. N Engl J Med 344:350-362 (2001).
7. Hamid, Q. A. & Minshall, E. M. Molecular pathology of allergic disease: I: lower airway disease. J Allergy Clin Immunol 105:20-36 (2000).
8. Holgate, S. T. & Polosa, R. Treatment strategies for allergy and asthma. Nat Rev Immunol 8:218-230 (2008).
9. Secor, E. R. et al. Oral Bromelain Attenuates Inflammation in an Ovalbumin-induced Murine Model of Asthma. Evid Based Complement Alternat Med 5:61-69 (2008).
10. Rothenberg, M. E. Eosinophilia. N Engl J Med 338:1592-1600 (1998).
11. Holgate, S. T. A brief history of asthma and its mechanisms to modern concepts of disease pathogenesis. Allergy, Asthma & Immunology Research 2:165-171 (2010).
12. Smith, A. D., Cowan, J. O., Brassett, K. P., Herbison, G. P. & Taylor, D. R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352:2163-2173 (2005).
13. Vahlkvist, S., Sinding, M., Skamstrup, K. & Bisgaard, H. Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure. J Allergy Clin Immunol 117:1272-1276 (2006).
14. Andreadis, A. A., Hazen, S. L., Comhair, S. A. & Erzurum, S. C. Oxidative and nitrosative events in asthma. Free Radical Biology & Medicine 35:213-225 (2003).
15. Sugiura, H. & Ichinose, M. Oxidative and nitrative stress in bronchial asthma. Antioxidants & Redox Signaling 10:785-797 (2008).
16. Yamamoto, Y. & Gaynor, R. B. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Current Molecular Medicine 1:287-296 (2001).
17. Batra, J., Chatterjee, R. & Ghosh, B. Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis. Indian Journal of Biochemistry & Biophysics 44:303-309 (2007).
18. Janssen-Heininger, Y. M. et al. Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proceedings of the American Thoracic Society 6:249-255 (2009).
19. Baeuerle, P. A. & Baltimore, D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53:211-217 (1988).
20. Edwards, M. R. et al. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacology & Therapeutics 121:1-13 (2009).
21. Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M. & Vignola, A. M. Asthma. From bronchoconstriction to airways inflammation and remodeling. American Journal of Respiratory and Critical Care Medicine 161:1720-1745 (2000).
22. Pauwels, R. A. et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361:1071-1076 (2003).
23. Lipworth, B. J. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Archives of Internal Medicine 159:941-955 (1999).
24. Bahceciler, N. N. et al. Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children. The Pediatric Infectious Disease Journal 19:215-218 (2000).
25. Roh, G. S. et al. Efficacy of a traditional Korean medicine, Chung-Sang-Bo-Ha-Tang, in a murine model of chronic asthma. Int Immunopharmacol 5:427-436 (2005).
26. Ko, E. et al. So-Cheong-Ryong-Tang, tradititional Korean medicine, suppresses Th2 lineage development. Biol Pharm Bull 27:739-743 (2004).
27. Mo, J. H. et al. Anti-allergic effects of So-Cheong-Ryong-Tang, a traditional Korean herbal medicine, in an allergic rhinitis mouse model. Eur Arch Otorhinolaryngol 270:923-930 (2013).
28. Lee, Y. C., Lee, J. C., Seo, Y. B. & Kook, Y. B. Liriopis tuber inhibit OVA-induced airway inflammation and bronchial hyperresponsiveness in murine model of asthma. J Ethnopharmacol 101:144-152 (2005).
29. Heo, H. J. et al. Effects of baicalin and wogonin on mucin release from cultured airway epithelial cells. Phytother Res 21:1130-1134 (2007).
30. Zhou, S., Potts, E. N., Cuttitta, F., Foster, W. M. & Sunday, M. E. Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma. Proc Natl Acad Sci USA 108:2100-2105 (2011).
31. Jang, B. C. et al. Catalase induces the expression of inducible nitric oxide synthase through activation of NF-kappaB and PI3K signaling pathway in Raw 264.7 cells. Biochemical Pharmacology 68:2167-2176 (2004).
32. Grigoriadis, G. et al. The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. The EMBO Journal 15:7099-7107 (1996).
33. Ahn, M. J., Koh, R. K., Kim, G. O. & Shin, T. K. Aqueous extract of purple Bordeaux radish, Raphanus sativus L. ameliorates ethanol-induced gastric injury in rats. Oriental Pharm Exp Med 13:247-252 (2013).
34. Ambikar, D. B. & Monhanta, G. P. Neuroprotective effect of petroleum ether, methanolic and aqueous extracts of flower heads of Sphaeranthus indicus on lipofuscinogenesis and fluorescence product in brain of D-galactose induced aging accelerated mice. Oriental Pharm Exp Med 13:301-306 (2013).
35. Kim, K. S. et al. Transcriptomic analysis of the bitter taste receptor-mediated glucagon-like peptide-1 stimulation effect of quinine. BioChip J 7:386-392 (2013).
36. Kim, K. H. et al. Aqueous extracts of Anemarrhena asphodeloides stimulate glucagon-like pepetide-1 secretion in enteroendocrine NCI-H716 cells. BioChip J 7:188-193 (2013).
37. Kim, K. S. et al. The Multi-Targeted Effects of Chrysanthemum Herb Extract Against Escherichia coli O157:H7. Phytother Res 27:1398-1406 (2013).
38. Ha, Y. W., Na, Y. C., Ha, I. J., Kim, D. H. & Kim, Y. S. Liquid chromatography/mass spectrometry-based structural analysis of new platycoside metabolites transformed by human intestinal bacteria. Journal of Pharmaceutical and Biomedical Analysis 51:202-209 (2010).
39. Whitehead, G. S., Walker, J. K., Berman, K. G., Foster, W. M. & Schwartz, D. A. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 285:L32-42 (2003).